Suchergebnisse

El presente artículo de investigación tiene como finalidad presentar los resultados de un análisis jurisprudencial realizado para evidenciar el estado actual de la garantía de los derechos de las víctimas del conflicto armado por bandas criminales en Colombia. Dicho estudio se desarrolló bajo un enfoque cualitativo y un método hermenéutico dirigido hacia la comprensión del significado de las estructuras escritas de las sentencias objeto de estudio mediante matrices de análisis y de análisis jurisprudencial. Como resultados se logra observar que la evolución jurisprudencial obedece a un desarrollo sociohistórico relacionado con la procura de los derechos de las víctimas. Conforme a lo anterior, se dan las siguientes categorías: comprensión del conflicto armado en sentido estrecho y en sentido amplio, la víctima y su reconocimiento ante grupos no identificados o bandas criminales y finalmente, el derecho fundamental que le asiste a las víctimas a ser incluidas en el Registro Único de Víctimas (RUV). Se concluye que las víctimas del conflicto armado han tenido una evolución jurisprudencial favorable a sus derechos, aunque quedan varios puntos por tratar que impiden su garantía efectiva.

In Europe, annual influenza vaccination is recommended to elderly. From 2011 to 2014 and in 2015-16, we conducted a multicentre test negative case control study in hospitals of 11 European countries to measure influenza vaccine effectiveness (IVE) against laboratory confirmed hospitalised influenza among people aged ≥65years. We pooled four seasons data to measure IVE by past exposures to influenza vaccination. We swabbed patients admitted for clinical conditions related to influenza with onset of severe acute respiratory infection ≤7days before admission. Cases were patients RT-PCR positive for influenza virus and controls those negative for any influenza virus. We documented seasonal vaccination status for the current season and the two previous seasons. We recruited 5295 patients over the four seasons, including 465A(H1N1)pdm09, 642A(H3N2), 278 B case-patients and 3910 controls. Among patients unvaccinated in both previous two seasons, current seasonal IVE (pooled across seasons) was 30% (95%CI: -35 to 64), 8% (95%CI: -94 to 56) and 33% (95%CI: -43 to 68) against influenza A(H1N1)pdm09, A(H3N2) and B respectively. Among patients vaccinated in both previous seasons, current seasonal IVE (pooled across seasons) was -1% (95%CI: -80 to 43), 37% (95%CI: 7-57) and 43% (95%CI: 1-68) against influenza A(H1N1)pdm09, A(H3N2) and B respectively. Our results suggest that, regardless of patients' recent vaccination history, current seasonal vaccine conferred some protection to vaccinated patients against hospitalisation with influenza A(H3N2) and B. Vaccination of patients already vaccinated in both the past two seasons did not seem to be effective against A(H1N1)pdm09. To better understand the effect of repeated vaccination, engaging in large cohort studies documenting exposures to vaccine and natural infection is needed. ; The Lithuanian I-MOVE + study sites were supported by a grant from the Research Council of Lithuania (SEN-03/2015). The I-MOVE + project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 634446. GlaxoSmithKline, Sanofi Pasteur and Sanofi Pasteur MSD financially supported the InNHOVE network. ; Sí